AMA Delegates Dismayed With Prevention Task Force
This article was originally published in The Gray Sheet
Executive Summary
A new American Medical Association policy expresses “concern” over the U.S. Preventive Services Task Force's recommendations on mammography and PSA screening. In the future, the task force should obtain input from disease specialists, it says. Some members of Congress agree.
You may also be interested in...
PSA Prostate Cancer Screening Does More Harm Than Good, USPSTF Concludes
The final recommendations are a major shift in policy for the commonly performed blood test, and one certain to face ongoing controversy.
Task Force Mammography Guidelines Present Challenges And Opportunities
Mammography coverage policies among public and private payers are not likely to be restricted, at least in the near term, by the U.S. Preventive Services Task Force's new breast cancer screening guidelines, but prospects for longer-term adjustments remain
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”